Through strategic guidance, visionary thinking, and a relentless pursuit of excellence, our senior executives steer SPT Labtech towards achieving its mission of making a real difference to human health through solving advanced laboratory challenges.
Learn more
Board of Directors
Our Board of Directors are committed to driving the long-term success and sustainability of SPT Labtech, providing expert guidance and oversight to execute the company’s ambitious commercial strategy.
Learn more
10
SPT Labtech and BellBrook Labs Introduce High-Throughput Screening Platform for Cancer Research
Continue reading
SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on firefly platform
Continue reading
5 Key Sample Management Automation Trends for 2025- 2026: An Interview with SPT Labtech’s Cory Tiller
Continue reading
As part of SPT Labtech’s wider strategic evolution across our core portfolios - including Cryo-EM, liquid handling, and sample management, a decision has been made not to provide any further chameleon instruments. This action allows us to focus on areas where we can have the greatest impact, particularly within Cryo-EM through increased focus on our Quantifoil® grids portfolio offering, as well as continuing to support our broader structural biology offering, including crystallography through our well-established mosquito instruments.
QUANTIFOIL Active grids are unique in being the first commercially produced grids with copper nano-wire covered bars to promote thin film formation through a process of “self-wicking”. This novel grid technology removes the variability of applying an externally applied filter paper to remove excess sample during blotting.